Table 2.
Univariate and multivariate analyses for survival in 133 OC patients.
| Variables | Univariate | Multivariate | ||
|---|---|---|---|---|
| P | HR | 95%CI | P | |
| variables related to OS | ||||
| Age (years) | 0.219 | |||
| Histological type | 0.914 | |||
| FIGO stage | <0.001 | 3.695 | (1.793–7.613) | <0.001 |
| Histologic grade | 0.009 | 1.664 | (1.101–2.513) | 0.016 |
| Residual disease (cm) | 0.022 | 1.682 | (1.093–2.591) | 0.018 |
| Ascites (ml) | 0.696 | |||
| Serum CA-125 level (U/ml) | 0.154 | |||
| Lymph node metastasis | <0.001 | 3.665 | (2.344–5.730) | <0.001 |
| Peritoneum metastasis | 0.001 | |||
| LRH1 expression level | 0.007 | |||
| variables related to DFS | ||||
| Age (years) | 0.487 | |||
| Histological type | 0.895 | |||
| FIGO stage | <0.001 | 3.437 | (1.641–7.200) | 0.001 |
| Histologic grade | 0.028 | 1.550 | (1.024–2.345) | 0.038 |
| Residual disease (cm) | 0.026 | 1.663 | (1.065–2.597) | 0.025 |
| Ascites (ml) | 0.855 | |||
| Serum CA-125 level (U/ml) | 0.281 | |||
| Lymph node metastasis | <0.001 | 3.857 | (2.431–6.120) | <0.001 |
| Peritoneum metastasis | <0.001 | |||
| LRH1 expression level | <0.001 | 1.535 | (1.017–2.318) | 0.041 |
FIGO, the Federation of Gynaecology and Obstetrics; OS, overall survival; DFS, disease-free survival; OC, ovarian cancer; HR, hazard ratio; CI, confidence interval.